Approvals/CIMA-AEMPS/LINAGLIPTINA PENSA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Approved

STANDARD

LINAGLIPTINA PENSA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG

Towa Pharmaceutical S.A.🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 650aad177bfad996
Drug Cima Aemps Name: LINAGLIPTINA PENSA 5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG
Register Number: 89394
Holder Company Name: Towa Pharmaceutical S.A.
Marketing Company Name: Towa Pharmaceutical S.A.
Authorization Date: 2024-02-27
Dosage Form: COMPRIMIDO RECUBIERTO CON PELÍCULA
Dose: 5 mg
Route Of Administration: VÍA ORAL
Prescription Type: Medicamento Sujeto A Prescripción Médica
Commercialized: No
Company Name: Towa Pharmaceutical S.A.

LINAGLIPTINA

5 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 27, 2024

Approval ID

650aad177bfad996

Type

Standard